Document Detail


Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
MedLine Citation:
PMID:  16551485     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Body weight gain is a worrying side effect of many new antipsychotic drugs. The mechanisms by which antipsychotic drugs increase weight in humans are not known. Attempts to model the metabolic effects of antipsychotic drugs in the animal have not been successful. Female rats appear to be sensitive to the effects of antipsychotics, but male rats less, and this does not match the clinical situation in humans. In previous rodent studies, antipsychotics were always given by daily gavage or injections. Antipsychotics have different pharmacokinetics in rodents and humans, and in the present study, we tested the hypothesis that the insensitivity of male rats to the effects of antipsychotics could be related to their mode of administration. Thus, we administered antipsychotic drugs mixed with the food. Animals were treated during 6 weeks with haloperidol (1mg/kg), olanzapine (1mg/kg), ziprasidone (10mg/kg), or a control solution. Animals were allowed to self-select food among three macronutrients (carbohydrates, lipids and proteins). Food selection was measured throughout the study. At the end of the study, body composition was measured by dissection and weighing of the rat's main organs and tissues. Mitochondrial thermogenesis was measured in brown adipose tissue in olanzapine-treated animals. Circulating leptin, insulin, glucose, triglycerides, cholesterol, high-density lipoprotein (HDL) were also assayed at the end of the study. The results show that none of the antipsychotic treatments modified caloric intake, food selection or body weight. Olanzapine did not alter mitochondrial thermogenesis. However, haloperidol and olanzapine induced a significant increase in adiposity and circulating leptin. Ziprasidone produced a moderate fat accumulation. It is concluded that mixing antipsychotic treatments with the food provides a reliable animal model of antipsychotic-induced fat accumulation.
Authors:
Julie Minet-Ringuet; Patrick C Even; Marc Goubern; Daniel Tomé; Renaud de Beaurepaire
Related Documents :
1120795 - Some effects of ovarian hormones on food intake and body weight in female rats.
15350685 - Safety evaluation of a triterpenoid-rich extract from bamboo shavings.
1161705 - The effect of methionine deficiency on body weight, food and energy utilization in the ...
18716045 - Peripheral, but not central, cb1 antagonism provides food intake-independent metabolic ...
10885105 - Genetically modified crops: methodology, benefits, regulation and public concerns.
24322875 - Western scrub-jays allocate longer observation time to more valuable information.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-03-23
Journal Detail:
Title:  Appetite     Volume:  46     ISSN:  0195-6663     ISO Abbreviation:  Appetite     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-06-19     Completed Date:  2007-01-12     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8006808     Medline TA:  Appetite     Country:  England    
Other Details:
Languages:  eng     Pagination:  254-62     Citation Subset:  IM    
Affiliation:
Laboratoire de Psychopharmacologie, Centre Hospitalier Paul Guiraud, 54 avenue de la République, 94806 Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / drug effects,  metabolism*
Animal Feed*
Animals
Antipsychotic Agents / administration & dosage,  adverse effects*,  therapeutic use
Benzodiazepines / administration & dosage,  adverse effects,  therapeutic use
Eating / drug effects*
Haloperidol / administration & dosage,  adverse effects,  therapeutic use
Male
Organ Size
Random Allocation
Rats
Rats, Sprague-Dawley
Thermogenesis / drug effects,  physiology
Weight Gain / drug effects*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 52-86-8/Haloperidol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.
Next Document:  Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga tox...